Comments

BioCardia Stock Price, Quotes and Forecasts

Q: What sector and industry does BioCardia (BCDA) operate in?

BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BCDANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.26

-0.30-11.72%

Pre-Market: 8:00 AM EDT

BioCardia (BCDA) Forecast

News Earnings BioCardia (BCDA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

BioCardia Stock Price, Quotes and Forecasts | NASDAQ:BCDA | Benzinga

Explore BioCardia stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BCDA.

Open	-
Close	-
Volume / Avg.	3.50K / 52.01K
Day Range	- - -
52 Wk Range	1.63 - 8.85
Market Cap	$10.36M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	1.3%
Days to Cover	1.02

Recent News

Why BioCardia (BCDA) Stock Is Falling Today

BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering.

Henry Khederian

Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Crude Oil Moves Higher; Dollar General Earnings Miss Estimates

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	3.50K / 52.01K
Day Range	- - -
52 Wk Range	1.63 - 8.85
Market Cap	$10.36M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	1.3%
Days to Cover	1.02

About BioCardia Inc.

Sector

Health Care

Industry

Biotechnology

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BioCardia (BCDA) stock?

You can purchase shares of BioCardia (NASDAQ:BCDA) through any online brokerage.

View our list of the best stock brokerages

Who are BioCardia (BCDA) competitors?

Other companies in BioCardia’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB), Imunon (NASDAQ:IMNN) and Evaxion Biotech (NASDAQ:EVAX).

What is the forecast, or price target, for BioCardia (BCDA) stock?

BioCardia has a consensus price target of $25.00.

What is the current price for BioCardia (BCDA)?

The stock price for BioCardia (NASDAQ: BCDA) is $2.26 last updated March 4, 2025 at 8:00 AM EST.

Does BioCardia (BCDA) pay a dividend?

There are no upcoming dividends for BioCardia.

When is BioCardia (NASDAQ:BCDA) reporting earnings?

BioCardia’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is BioCardia (BCDA) going to split?

There is no upcoming split for BioCardia.

What sector and industry does BioCardia (BCDA) operate in?

BioCardia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.